AzTrials
AzTrials

Developmental Dysplasia of the HipNCT04007016

A New Pelvic Osteotomy Method for Open Reduction

An observational study of Developmental Dysplasia of the Hip, run by Yuxi Su.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Developmental dysplasia of the hip (DDH) was one of the most common hip disorders disease in children. Pemberton osteotomy (PO) was one of the most widely used by the pediatric orthopedic surgeons. In our clinical work, the investigators found some defect the operation procedure. Read more about this study

Who is it for?
Ages 2 to 8 years
Conditions the study is for
Developmental Dysplasia of the Hip
What is being tested?
a new osteotomy from the inner "L shaped" iliac osteotomy
Type of treatment
Surgery or procedure
How many people
2 participants
Where
No sites listed yet
Study dates
1 Mar 2016to 1 Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: All patients were evaluated and treated in the same hospital and the same surgeon did all the operation. The study was carried out between Mar 2016 and May 2018.

Who may be able to join

  • over two years old
  • open reduction and acetabular osteotomy
  • diagnosed as developmental dysplasia of the hip

Who cannot join

  • a previous history of DDH surgery
  • teratologic dislocations
  • cerebral palsy
  • other spastic or neuromuscular disease

About this study

Official title: A New Pelvic Osteotomy Method for Open Reduction in the Treatment of Developmental Dysplasia of the Hip in Children

Developmental dysplasia of the hip (DDH) was one of the most common hip disorders disease in children. Pemberton osteotomy (PO) was one of the most widely used by the pediatric orthopedic surgeons. In our clinical work, the investigators found some defect the operation procedure. When the surgeons were not familiar to the PO, it may injured the triradiate cartilage or easily be absorbable of the distal iliac. Here, the investigators found a new pelvic osteotomy just from the inner "L shaped" iliac osteotomy (ILSO) to treat DDH. This approach was in a visible part of the sciatic notch and not presumed to be in the ischium, completely out of sight. Comparing to the PO method, the investigators' operation method was easy to master and had less complications.

Being tested
a new osteotomy from the inner "L shaped" iliac osteotomy
Medical subject headings
Developmental Dysplasia of the Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • a new osteotomy from the inner "L shaped" iliac osteotomyProcedure or surgery

    There were two ostectomies were used in the osteotomy. The first was was a cured and 5mm width and the second one was straight 1.5cm width. All the directions was started from the inner to outer just a bove the triradiate cartilage and its shape like"L"

Study groups in NCT04007016
Study groupRoleWhat they receive
Pemberton osteotomy (PO)PO group received Pemberton osteotomy
inner "L shaped" iliac osteotomy (ILSO)ILSO group received inner "L shaped" iliac osteotomy
Receives: Procedure: a new osteotomy from the inner "L shaped" iliac osteotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. preoperative acetabular index

    preoperative acetabular index by measure the postoperative X-ray

    Measured: 6th month after surgery

  2. Wiberg's mean center-edge angle

    center-edge angle by measure the postoperative X-ray

    Measured: 6th month after surgery

Secondary outcomes (2)
  1. blood loss

    blood loss during surgery

    Measured: 1st day after surgery

  2. avascular necrosis (AVN)

    avascular necrosis (AVN) of the femoral head according to the Kalamchi and McEwen classification

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2019
  2. Study start1 Mar 2016
  3. Primary completion1 May 2018
  4. Study completion1 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04007016
Sponsor's protocol ID
Yuxi-Guoxin 201906
Status last verified
Jul 2019
First submitted
28 Jun 2019
Last updated
5 Jul 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Developmental Dysplasia of the Hip, run by Yuxi Su.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

preoperative acetabular index (time frame: 6th month after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in